Perry, Meghan RPrajapati, Vijay KMenten, JorisRaab, AndreaFeldmann, JoergChakraborti, DipankarSundar, ShyamFairlamb, Alan HBoelaert, MarleenPicado, Albert2016-07-272016-07-272015-03-02Perry, M R, Prajapati, V K, Menten, J, Raab, A, Feldmann, J, Chakraborti, D, Sundar, S, Fairlamb, A H, Boelaert, M & Picado, A 2015, 'Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India : a retrospective cohort study', PLoS Neglected Tropical Diseases, vol. 9, no. 3, e0003518. https://doi.org/10.1371/journal.pntd.00035181935-2735ORCID: /0000-0002-0524-8254/work/31459816ORCID: /0000-0003-2058-0105/work/72631117http://hdl.handle.net/2164/6263Funding: This work was supported by a Clinical PhD Fellowship to MRP (090665) and a Principal Research Fellowship to AHF (079838) from the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.4656431engSDG 3 - Good Health and Well-beingAdolescentAdultAntimony Sodium GluconateAntiprotozoal AgentsArsenicChildChild, PreschoolCohort StudiesDrug ResistanceFemaleHumansIndiaLeishmaniasis, VisceralLogistic ModelsMaleMiddle AgedRetrospective StudiesTreatment FailureQD ChemistryWellcome Trust090665079838QDJournal article10.1371/journal.pntd.000351893